USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing
20-Oct-2023
North America
Market Research
K960-01-00-00-00
HC_2023_255
The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this integration improves operational effectiveness in healthcare settings. POCT options play a significant role as well, offering on-the-spot HbA1c testing for rapid outcomes and prompt action, further improving patient satisfaction and saving valuable assets.
Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market. By promoting industrial convergence and the development of integrated solutions, these partnerships position companies as market leaders with cutting-edge products. Companies that capitalize on this trend early on have an advantage over competitors and create new business prospects by addressing the rising need for all-inclusive diabetes management products.
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the HbA1c Testing Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of the Study
Segmentation by Setting
Segmentation by End Users
Segmentation by Technology
Key Competitors
Global Diabetes Highlights, 2021
Number of People with Diabetes, 2021–2045
Top 10 Countries or Territories for Number of Adults
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Region
Revenue Forecast Analysis by Region
Revenue Forecast Analysis by Region (continued)
Revenue Forecast Analysis by Region (continued)
Revenue Forecast Analysis by Region (continued)
Revenue Forecast Analysis by Region (continued)
Revenue Forecast By Setting
Revenue Forecast Analysis by Setting
Revenue Forecast Analysis by Setting (continued)
Revenue Forecast by End Users
Revenue Forecast Analysis by End Users
Revenue Forecast by Technology
Revenue Forecast Analysis by Technology
Revenue Forecast Analysis by Technology (continued)
Pricing Trends and Analysis
Pricing Trends and Analysis (continued)
Key Pricing Strategies Adopted by Players
Future Aspect of Pricing
Global HbA1c Testing Market—Notable Activities
Global HbA1c Testing Market—Notable Activities (continued)
Global HbA1c Testing Reimbursement Pathways
Competitive Environment
Companies to Watch—Abbott Laboratories
Companies to Watch—Roche Diagnostics
Companies to Watch—Siemens Healthineers
Companies to Watch—Beckman Coulter
Companies to Watch—Tosoh Corporation
Companies to Watch—Bio-Rad Laboratories
Companies to Watch—EKF Diagnostics
Companies to Watch—Erba Diagnostics, Inc.
Companies to Watch—Diazyme Laboratories
Companies to Watch—PTS Diagnostics
Companies to Watch—Trinity Biotech
Competitive Mapping by HbA1c Offering Parameters
Competitive Mapping by HbA1c Offering Parameters (continued)
Growth Opportunity Summary
Growth Opportunity 1—Tailoring HbA1c Testing Approaches to Individual Patient Characteristics
Growth Opportunity 1—Tailoring HbA1c Testing Approaches to Individual Patient Characteristics (continued)
Growth Opportunity 2—Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing
Growth Opportunity 2—Advancements in POCT for Accurate, Affordable, and User-friendly HbA1c Testing (continued)
Growth Opportunity 3—Capturing Opportunities in Growing Diabetes Care Markets
Growth Opportunity 3—Capturing Opportunities in Growing Diabetes Care Markets (continued)
Growth Opportunity 4—Diabetes HbA1c Screening for Better Care and Management
Growth Opportunity 4—Diabetes HbA1c Screening for Better Care and Management (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Chandni Hussain |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Global Diagnostic Testing Trends |
| Keyword 2 | Hemoglobin A1C Test Forecast |
| Keyword 3 | A1C Testing Market Analysis |
| Podcast | No |
| WIP Number | K960-01-00-00-00 |
Global Hemoglobin A1C Testing Market, Forecast to 2028
$4,950.00
Special Price $3,712.50 save 25 %